We’ve tracked the info to present the top CEO pay packages in biopharma, ranging from nearly $60 million in 2018 down to $16 million.
The big names always turn up near the top of yearly sales rankings and this year is no different. Many companies on this list have faced big patent losses in…
This year looks like the end of the line for some of the biggest brands in the pharma industry.
The top 10 cancer drug makers of 2024.
Despite advances in life sciences and the corporate world, professional women still face numerous hurdles, even those at the top of their fields.
The top 10 drugmakers in 2024 will hold 35% of the total biopharma market share, or more than $420 billion in sales that year.
GSK, Merck, Sanofi, Pfizer and Seqirus topped the world's biggest vaccine companies list by 2017 revenue.
J&J's retiring Group Worldwide Chair Sandra Peterson, with $17.18 million in 2017 compensation, was the top-paid female biopharma exec.
In many ways, 2017 was a "wait-and-see" year for biopharma. But things are picking up speed in 2018.
Roche's Rituxan, Pfizer's Lyrica and other blockbusters lead 2018's top patent expirations.
